Holds one active US DMF for nintedanib, filing since 2023. Its GMP is recognised in 3 markets.
Holds one active US DMF for nintedanib, filing since 2023. Its GMP is recognised in 3 markets.
Holds one active US DMF for nintedanib, filing since 2019. Its GMP is recognised in 4 markets.
Holds one active US DMF for nintedanib, filing since 2023. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for nintedanib, filing since 2024. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for nintedanib, filing since 2018. Its GMP is recognised in 2 markets.
This page filters the worldwide Nintedanib manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for nintedanib and what filings they hold.
Chat with Fred, your AI analyst